Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2003
11/12/2003EP1359942A1 Targetted anti-tumor drug delivery systems
11/12/2003EP1359937A1 Altered peptide ligands
11/12/2003EP1359932A2 Tip39 polypeptides
11/12/2003EP1359922A1 Novel receptors for $i(helicobacter pylori) and use thereof
11/12/2003EP1359909A2 Anticancer treatment using triptolide prodrugs
11/12/2003EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/12/2003EP1359904A2 P27 prevents cellular migration
11/12/2003EP1359816A1 Combination of probiotics
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1200412B1 Imidazole antiproliferative agents
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003EP1146895B1 Thrombopoietin compositions for increasing circulating platelets
11/12/2003EP1137400B1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period toff, verfahren zu seiner herstellung und anlage zur durchfuhrung des verfahrens
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1051187B1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
11/12/2003EP0847272B1 LIPOSOMAL p-ETHOXY OLIGONUCLEOTIDES
11/12/2003EP0817623B1 Medicaments for the selective treatment of tumour tissues
11/12/2003EP0760657B1 Novel potent inducers of terminal differentiation and methods of use thereof
11/12/2003EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications
11/12/2003CN1455813A Human myeloma cell line
11/12/2003CN1455781A Discrimination between GnRH-Ôàáand GnRH-Ôàí"
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/12/2003CN1455765A Novel retinoid derivatives and production method thereof and anti-cancer pharmaceutical composition comprising same
11/12/2003CN1455683A Drugs for diagnosis of tissue-reproductive activity or treatment of proliferative disease
11/12/2003CN1455680A MUCl extracellular domain and cancer treatment compositions and methods derived therefrom
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1455673A Antibiotics from bacteria isolated from amphibian skin and biological active extrat derivated from same
11/12/2003CN1455672A Use of 2-methylene-19-Nor-20(s)-1 alpha, 25-dihydroxy vitamin D3 to increase bone strength
11/12/2003CN1454895A Use of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethyl chalcone for preparing anticancer medicine
11/12/2003CN1454615A Sesquiterpene injection, and preparing method and use thereof
11/12/2003CN1454614A Anticancer capsule and preparing method thereof
11/12/2003CN1454611A Medicine for curing lung cancer
11/12/2003CN1127514C Antineoplastic peptides
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127500C Substituted bisindolymaleimides for inhibition of cell proliferation
11/12/2003CN1127480C Colchicine derivative and its treatment use
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646143 Anticancer agents; skin disorders
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646129 Cyanoguanidines as cell proliferation inhibitors
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6646008 Administering peroxisome proliferator activated receptor(PPAR) and retinoid acid receptor agonists such as 6-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl) nicotinic acid, for prophylaxis of tumors
11/11/2003US6645999 Lactacystin analogs
11/11/2003US6645998 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors
11/11/2003US6645982 Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645972 Administering nucleoside analogues such as beta-L-dioxolane cytidine as tyrosine kinase inhibitors or anticarcinogenic agents
11/11/2003US6645955 3,6-dihydroxy-24-amidyl steroid derivatives
11/11/2003US6645951 Benzopyran or thiobenzopyran derivatives
11/11/2003US6645950 Benzimidazole vascular damaging agents
11/11/2003US6645946 Delivery of a therapeutic agent in a formulation for reduced toxicity
11/11/2003US6645937 Methods using persephin and related growth factors
11/11/2003US6645935 Synthesis of glycoconjugates of the lewis Y epitope and uses thereof
11/11/2003US6645933 Polypeptide that binds extracellular domain of human Flt4 receptor tyrosine kinase; genetic engineering; endothelial cell growth factors and genes
11/11/2003US6645753 Polynucleotides; antisense agents; MAP-kinases; nucleotide sequences; use of polypeptides to identify agents modulating signal transduction leading to cell proliferation, differen-tiation, survival and treatment of such conditions (cancer)
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003CA2290332C Optically pure androgen mediator
11/11/2003CA2264569C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
11/11/2003CA2143756C N-cyano-n'-pyridylguanidines as serotonin antagonists
11/06/2003WO2003091442A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/06/2003WO2003091432A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
11/06/2003WO2003091383A2 Epha2 antigen t epitopes
11/06/2003WO2003091259A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003WO2003091258A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003091257A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
11/06/2003WO2003091255A1 Inhibitors of checkpoint kinases (wee1 and chk1)
11/06/2003WO2003091252A1 Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
11/06/2003WO2003091251A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091246A1 Pyrrole derivatives as inhibitors of erk2 and uses thereof
11/06/2003WO2003091242A1 Novel thiol derivative, process for producing the same and use thereof
11/06/2003WO2003091241A1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists
11/06/2003WO2003091239A1 Estrogen receptor modulators
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091215A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo’ b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003WO2003091214A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
11/06/2003WO2003090818A2 Drug-delivery endovascular stent and method for treating restenosis
11/06/2003WO2003090785A1 Methods and conpositions for treating, preventing or delaying onset of a neoplasm
11/06/2003WO2003090779A1 Remedy for lung cancer
11/06/2003WO2003090778A2 Dna vaccine combined with an inducer of tumor cell apoptosis
11/06/2003WO2003090774A1 Mannose binding lectin and uses thereof
11/06/2003WO2003090757A1 Pharmaceutical compositions of phospholipid derivatives
11/06/2003WO2003090752A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003090751A1 Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
11/06/2003WO2003090748A1 Use of compounds having ccr antagonism
11/06/2003WO2003090740A1 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori
11/06/2003WO2003090737A2 Methods and compositions for treatment of cancer pain
11/06/2003WO2003090722A2 Microparticle pharmaceutical compositions for intratumoral delivery
11/06/2003WO2003090720A1 High drug load tablet
1 ... 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 ... 2211